ARCT Arcturus Therapeutics Holdi...

Nasdaq arcturusrx.com


$ 23.00 $ 1.65 (7.67 %)    

Tuesday, 21-Oct-2025 17:56:34 EDT
QQQ $ 610.29 $ -0.16 (-0.03 %)
DIA $ 469.10 $ 2.20 (0.47 %)
SPY $ 670.98 $ -0.01 (0 %)
TLT $ 91.99 $ 0.45 (0.49 %)
GLD $ 376.61 $ -25.91 (-6.43 %)
$ 23.16
$ 21.45
$ 21.24 x 131
$ 24.00 x 100
$ 20.80 - $ 24.17
$ 8.04 - $ 24.17
2,265,657
na
628.9M
$ 2.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-06-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

 cathie-woods-ark-bets-big-on-solana-treasury-play-makes-162m-investment-in-brera-holdings-as-stock-explodes-225

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and b...

 hc-wainwright--co-assumes-arcturus-therapeutics-at-buy-announces-price-target-of-60

HC Wainwright & Co. analyst Andrew S. Fein assumes Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and announces P...

 wells-fargo-maintains-overweight-on-arcturus-therapeutics-lowers-price-target-to-42

Wells Fargo analyst Yanan Zhu maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Overweight and lowers the price target fr...

 citigroup-maintains-buy-on-arcturus-therapeutics-raises-price-target-to-49

Citigroup analyst Yigal Nochomovitz maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target fro...

 arcturus-therapeutics-q2-eps-034-beats-096-estimate-sales-28301m-beat-22435m-estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of...

Core News & Articles

https://www.bloomberg.com/news/articles/2025-08-04/south-africa-gates-step-in-after-us-defunds-hiv-research

 scotiabank-maintains-sector-outperform-on-arcturus-therapeutics-raises-price-target-to-35

Scotiabank analyst Greg Harrison maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Sector Outperform and raises the price...

 arcturus-phase-2-interim-results-for-arct-810-in-otc-deficiency-shows-normalized-glutamine-levels-improved-urea-cycle-function-continues-to-be-safe-and-well-tolerated-at-all-tested-dose-levels-virtual-kol-presentation-at-1200-pm-et-june-30-2025

ARCT-810 significantly and consistently reduces biomarker glutamine to levels within normal range 15N-ureagenesis data provide...

 arcturus-therapeutics-reveals-interim-phase-2-multiple-dose-data-for-ornithine-transcarbamylase-deficiency-program

ARCT-810 significantly and consistently reduces biomarker glutamine to levels within normal range15N-ureagenesis data provide f...

 scotiabank-initiates-coverage-on-arcturus-therapeutics-with-sector-outperform-rating-announces-price-target-of-32

Scotiabank analyst Greg Harrison initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Sector Outperform rating a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION